Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03325777 · ClinicalTrials.gov registry record · NA

Approach Bias Retraining to Augment Smoking Cessation

A NA study, sponsored by Jasper A. Smits.

Completed
Registry status
NA
Development phase
96
Enrollment target

NCT03325777 is a NA study that has completed, run by Jasper A. Smits. The registered enrollment target is 96 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03325777, a NA study, has completed, sponsored by Jasper A. Smits.

COMPLETED
Registry status
NA
Development phase
96 participants
Enrollment target

Study Summary

Tobacco use is the most preventable cause of disease, disability, and death in the United States. Standard smoking cessation care (cognitive behavioral therapy and nicotine replacement therapy), is effective in approximately 20% of the cases, clearly indicating there is substantial room for improvement. Current work suggests that despite standard interventions, continued substance abuse may result from addictive behaviors governed partly through automatic processes that exert their influence outside conscious control. This is important from a treatment perspective, as we should develop treatments to target implicit processes. Among a number of promising targets for intervention, cognitive biases are important to address as they have been implicated as maintenance factors for addiction. Approach bias, defined as the automatically activated action tendency to approach smoking-related stimuli, is a relatively novel cognitive bias and has been related to failed smoking cessation. A recently developed task for approach bias assessment is the Approach Bias Retraining (ABR), a computerized joystick task increasingly used to measure automatic approach tendencies in addiction research. This clinical trial will evaluate a smoking cessation intervention that integrates standard care with approach bias retraining. Results will provide novel information regarding the potential benefits of engaging implicit cognitive biases as a means to augment traditional smoking cessation therapy. This study has the potential to help individuals attempting to quit smoking and, ultimately, provide unique information about the importance of targeting implicit processes to complement standard care.

Interventions

  • BEHAVIORAL Approach Bias Retraining
  • BEHAVIORAL SHAM Training

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2017-11-29
Est. Completion 2021-10-08
Phase NA

Sponsor

Jasper A. Smits

8 total trials

What the Registry Record Tells You About NCT03325777

The ClinicalTrials.gov registry entry for NCT03325777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jasper A. Smits, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Approach Bias Retraining is the first listed.

NCT03325777 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03325777 about?

NCT03325777 is a clinical study titled "Approach Bias Retraining to Augment Smoking Cessation". Tobacco use is the most preventable cause of disease, disability, and death in the United States. Standard smoking cessation care (cognitive behavioral therapy and nicotine replacement therapy), is effective in approximately 20% of the cases, clearly indicating there is substantial room for improvem...

What is the current status of trial NCT03325777?

This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2017-11-29. Estimated completion is 2021-10-08.

What interventions are being tested in trial NCT03325777?

The interventions under investigation include: Approach Bias Retraining (BEHAVIORAL), SHAM Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03325777?

This trial is sponsored by Jasper A. Smits, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.